What is CHARGE (Coloboma, Heart defect, Atresia choanae, Restricted growth and development, Genital abnormality, Ear abnormality) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

CHARGE syndrome is a rare genetic disorder characterized by coloboma, heart defects, atresia of nasal choanae, retardation of growth and development, genitourinary anomalies, and ear anomalies, caused by mutations in the CHD7 gene, as defined in the most recent guidelines 1.

Key Features of CHARGE Syndrome

  • Coloboma (eye defect)
  • Heart defects
  • Atresia choanae (blocked nasal passages)
  • Retarded growth and development
  • Genital abnormalities
  • Ear abnormalities The diagnosis of CHARGE syndrome is based on clinical findings, with genetic testing confirming the CHD7 mutation in about 60-70% of cases, according to the european society for immunodeficiencies guidelines for the management of patients with congenital athymia 1.

Management and Treatment

Treatment for CHARGE syndrome focuses on managing specific symptoms through a multidisciplinary approach, including:

  • Surgical interventions for heart defects or choanal atresia
  • Hearing aids or cochlear implants for hearing loss
  • Vision correction
  • Feeding support
  • Developmental therapies Each patient requires an individualized care plan due to the variable presentation of the syndrome, as emphasized in the guidelines 1.

Prognosis and Outcome

The prognosis for CHARGE syndrome varies widely depending on the severity of features, with some individuals leading relatively independent lives while others require lifelong support, highlighting the importance of early intervention and regular follow-up with specialists to monitor and address complications as they arise throughout the patient's life 1.

From the Research

Definition and Characteristics of CHARGE Syndrome

  • CHARGE syndrome is a rare congenital condition with multiple malformations, characterized by the acronym CHARGE, which summarizes six cardinal features: Coloboma, Heart defect, Atresia choanae, Retarded growth and development, Genital anomalies, and Ear anomalies/deafness 2, 3, 4, 5.
  • The syndrome is caused by pathogenic variants in the CHD7 gene and clinically characterized by a wide range of anomalies with variable expression 4, 5.
  • The estimated incidence of CHARGE syndrome ranges from 0.1-1.2/10,000 births, depending on professional recognition 2, 3.

Clinical Features and Malformations

  • Coloboma mainly affects the retina, and choanal atresia may be membranous or bony, bilateral or unilateral 2, 3.
  • Major and minor congenital heart defects occur in 75-80% of patients, with tetralogy of Fallot being the most common cyanotic heart defect 3.
  • Mental retardation is variable, with intelligence quotients (IQ) ranging from normal to profound retardation 2, 3.
  • Under-development of the external genitalia is a common finding in males, but less apparent in females 3.
  • Ear abnormalities include unusually shaped ears and hearing loss, which can be conductive and/or nerve deafness, ranging from mild to severe deafness 2, 3.

Diagnosis and Management

  • CHARGE syndrome is primarily a clinical diagnosis, and CHD7 analysis can be helpful in the diagnostic process, but the phenotype cannot be predicted from the genotype 5.
  • A multidisciplinary approach is necessary for the management of CHARGE syndrome, including medical follow-up, surgical interventions, and rehabilitation services 2, 3, 4.
  • Cochlear implantation can be an effective option for hearing rehabilitation in children with CHARGE syndrome, regardless of the extent of inner ear anomalies and intellectual faculties 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[The CHARGE syndrome].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008

Research

CHARGE syndrome.

Orphanet journal of rare diseases, 2006

Research

Growth in CHARGE syndrome: optimizing care with a multidisciplinary approach.

Journal of multidisciplinary healthcare, 2019

Related Questions

What is the recommended management for Gastroesophageal Reflux Disease (GERD) in patients with CHARGE (Coloboma, Heart defect, Atresia choanae, Restricted growth and development, Genital abnormality, Ear abnormality) syndrome?
What is the management approach for liver disease in individuals with CHARGE (Coloboma, Heart defect, Atresia choanae, Restricted growth and development, Genital abnormality, Ear abnormality) syndrome?
What is the likely diagnosis for a patient with unilateral cryptorchidism, brachydactyly, sensorineural hearing loss, craniofacial abnormalities, and mood disorder?
What is CHARGE (Coloboma, Heart defect, Atresia choanae, Restricted growth and development, Genital abnormality, and Ear abnormality) syndrome compared to Tetralogy of Fallot (TOF)?
What is the appropriate management for a patient with facial swelling, fatigue, and mouth sores following infectious mononucleosis (mono), with negative results for sexually transmitted diseases (STDs) and herpes?
What is the next step in managing a patient with persistent fatigue and mild abdominal pain one month after a diagnosis of infectious mononucleosis (mono), with a previously normal complete blood count (CBC) and positive mononucleosis test?
Is prophylactic Lovenox (enoxaparin) indicated for a patient with a history of pulmonary embolism (PE) and deep vein thrombosis (DVT) who has experienced a miscarriage?
What are the implications of Aortic valve replacement with Eliquis (Apixaban)?
What is Noonan syndrome?
What is the significance of free Prostate-Specific Antigen (PSA)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.